Jonathan Symonds

Head-Corporate Finance & Strategy at Mesoblast Ltd.

Jonathan Symonds

Jonathan Symonds

Head-Corporate Finance & Strategy at Mesoblast Ltd.

Overview
Career Highlights

Novartis Corporation
Novartis AG
AstraZeneca Plc

RelSci Relationships

4964

Number of Boards

17

Birthday

1959

Age

61

Number of Awards

1

Contact Data
Trying to get in touch with Jonathan Symonds? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jonathan Symonds likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Interim Chief Executive Officer at Alexion Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former President at MedImmune LLC

Relationship likelihood: Strong

Co-Founder at Condorcet LP

Relationship likelihood: Strong

Co-Founder at Proteus Digital Health, Inc.

Relationship likelihood: Strong

Co-Founder at Proteus Digital Health, Inc.

Relationship likelihood: Strong

Former Group Chief Executive Officer & Executive Director at HSBC Holdings Plc

Relationship likelihood: Strong

Regional Head of Europe at Banco Santander SA

Relationship likelihood: Strong

Professional at Sudbrook Associates LLP

Relationship likelihood: Strong

Former Director at Closure Medical Corp.

Relationship likelihood: Strong

Chief Executive Officer, Sumitovant at Roivant Sciences Ltd.

Relationship likelihood: Strong

Paths to Jonathan Symonds
Potential Connections via
Relationship Science
You
Jonathan Symonds
Head-Corporate Finance & Strategy at Mesoblast Ltd.
Education
B.A. in Business Finance with First Class
Class of 1980

Founded in 1952, University of Hertfordshire is the UK's leading business-facing university and an exemplar in the sector. It is innovative and enterprising and challenges individuals and organisations to excel. We will shape the next generation of business-facing universities. We will continue to be an exemplar in the sector and we will play a leading role in addressing the economic and social challenges facing the UK in increasingly competitive global markets. Innovation, creativity and an enterprising mindset will be the defining characteristics of our University. We will provide flexible and transformational learning and commit to adding value to our partners and delivering positive and productive engagements with business, industry and the professions. The University will continue to play a central role in the local and regional economy, contributing positively to its social and economic development, and we will build our international profile and global reputation. An innovative and enterprising university, challenging individuals and organisations to excel.

Memberships
Career History
Head-Corporate Finance & Strategy
2014 - Current

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Senior Adviser
Current

GHO Capital is an active manager that analyses healthcare trends to invest in mid-market well-established companies with a European presence and global potential.^They focus both on sector specialization and market fundamentals, seeking companies in the PharmaBio, MedTech, Outsourced services and Patient services sectors that offer a combination of double-digit top line growth and international expansion possibilities.^GHO Capital works alongside management teams taking an active role in the company’s growth and development.^

Deputy Group Chairman, Senior Independent Director
Current

HSBC Holdings Plc engages in the provision of banking and financial services. It operates through the following business segments: Retail Banking and Wealth Management, Commercial Banking, Global Banking and Markets, Global Private Banking, and Corporate Centre. The Retail Banking and Wealth Management segment consists of retail banking, wealth management, asset management, and insurance. The Commercial Banking segment offers banking products and services. The Global Banking and Markets segment includes transaction banking, financing, advisory, capital markets, and risk management services. The Global Private Banking offers transaction banking, financing, advisory, capital markets and risk management services to high net worth individuals and families. The Corporate Centre segment is comprises of central treasury, including balance sheet management, other legacy businesses, interests in associates and joint ventures, central stewardship costs and the UK bank levy. The company was founded on January 1, 1959 and is headquartered in London, the United Kingdom.

Boards & Committees
Non-Executive Director
2004 - 2007

Diageo Plc engages in the production and distribution of alcoholic beverages. Its brands include Johnnie Walker, Crown Royal, JeB, Buchanan's, Windsor and Bushmills whiskies, Smirnoff, Ciroc and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray, and Guinness. It operates through the following geographical segments: North America; Europe and Turkey; Africa; Latin America and Caribbean; Asia Pacific; ISC; and Corporate and Other.

Chairman
Prior

The 100 Group is a British private company located in London. The firm engages in development of business.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2011
Treasury & Risk Magazine - 100 Most Influential People in Finance
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jonathan Symonds. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jonathan Symonds's profile does not indicate a business or promotional relationship of any kind between RelSci and Jonathan Symonds.